⌘K

Login Start Free

Home/Filings/4/0001348362-19-000008

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001348362-19-000008

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 5:26 PM ET

Size

9.6 KB

Accession

0001348362-19-000008

Insider Transaction Report

Form 4

Period: 2019-12-30

Lexaria Bioscience Corp.LXRP

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Other
Stock Options
2019-12-30$0.09/sh+550,000$49,500→ 700,000 total
Exercise: $0.09From: 2015-03-26Exp: 2020-03-26→ Common Shares (550,000 underlying)

Holdings

Stock Options
Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ Common Shares (300,000 underlying)
850,000
common shares
(indirect: Private Holding Company)
1,622,250
Stock Options
Exercise: $0.09From: 2015-03-26Exp: 2020-03-26→ Common Shares (550,000 underlying)
550,000
Stock Options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (400,000 underlying)
1,250,000

Footnotes (1)

[F1]Cancellation of Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 5:26 PM ET
Size: 9.6 KB

View on SEC.gov